Trinity Biotech reported $41.12M in Current Assets for its fiscal quarter ending in December of 2024.


Current Assets Change Date
Abbott USD 24.47B 1.32B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Bio-Rad Laboratories USD 2.81B 225.5M Jun/2025
EDAP TMS EUR 69.88M 5.94M Dec/2024
J&J USD 71.55B 15.66B Mar/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Siemens EUR 65.79B 840M Jun/2025
Thermo Fisher Scientific USD 24.58B 1.21B Jun/2025
Tosoh JPY 727.66B 26.72B Jun/2025
Trinity Biotech USD 41.12M 4.96M Dec/2024
Veracyte USD 414.68M 31.53M Jun/2025